The DOI matches its Crossref record; the references it cites are not checked yet.
SOD1 Suppression with Adeno-Associated Virus and MicroRNA in Familial ALS
Open accessAbstract
) were treated with a single intrathecal infusion of adeno-associated virus encoding a microRNA targeting SOD1. In Patient 1, SOD1 levels in spinal cord tissue as analyzed on autopsy were lower than corresponding levels in untreated patients with SOD1-mediated ALS and in healthy controls. Levels of SOD1 in cerebrospinal fluid were transiently and only slightly lower in Patient 1 but were not affected in Patient 2. In Patient 1, meningoradiculitis developed after the infusion; Patient 2 was pretreated with immunosuppressive drugs and did not have this complication. Patient 1 had transient improvement in the strength of his right leg, a measure that had been relatively stable throughout his disease course, but there was no change in his vital capacity. Patient 2 had stable scores on a composite measure of ALS function and a stable vital capacity during a 12-month period. This study showed that intrathecal microRNA can be used as a potential treatment for SOD1-mediated ALS.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, recent studies suggest that corticosteroids alone may not be suf fi cient.”
From A versatile toolkit for overcoming AAV immunity (2022) · cites this paper as [14]
In the citing paper
“In contrast, lower T cell responses and NAbs were observed in a second patient who was received a different immunosuppressant regimen that includes rituximab and sirolimus in addition to corticosteroids prior to AAV delivery”
From A versatile toolkit for overcoming AAV immunity (2022) · cites this paper as [14]
In the citing paper
“In another clinical study for ALS, one patient developed meningoradiculitis after intrathecal AAV delivery in spite of methylprednisolone and prednisone usage (14).”
From A versatile toolkit for overcoming AAV immunity (2022) · cites this paper as [14]
In the citing paper
“In a AAVrh10-microRNA study delivering 4.2×1014 vg intrathecally into two adult patients, the first developed meningoradiculitis after intrathecal infusion despite corticosteroids (IV methylprednisolone on day 0 and oral prednisone tapered over 4 weeks).”
From Immunomodulation in Administration of RAAV: Preclinical and Clinical Adjuvant Pharmacotherapies (2021) · cites this paper as [29]
In the citing paper
“In the second patient, the addition of rituximab and rapamycin to the regimen resulted in a lower increase of NAb and T-cell response (29) and these drugs are further discussed.”
From Immunomodulation in Administration of RAAV: Preclinical and Clinical Adjuvant Pharmacotherapies (2021) · cites this paper as [29]
Citations
The citation lists are queued
They are fetched later and appear here then.
References 17 · Cited by 264
Metadata
- Authors
- Mueller, C., Berry, J. D., McKenna-Yasek, D. M., Gernoux, G., Owegi, M. A., Pothier, L. M., Douthwright, C. L., Gelevski, D., Luppino, S. D., Blackwood, M., Wightman, N. S., Oakley, D. H., Frosch, M. P., Flotte, T. R., Cudkowicz, M. E., & Brown, R. H.
- Affiliations
- University of Massachusetts Chan Medical School (US)
- From the Horae Gene Therapy Center, Department of Pediatrics, University of Massachusetts Medical School (UMMS) (C.M., G.G., M.B., T.R.F.), and the Department of Neurology, UMMS and UMass Memorial Medical Center (D.M.M.-Y., M.A.O., C.L.D., N.S.W., R.H.B.), Worcester, and the Healey Center for ALS, Department of Neurology (J.D.B., L.M.P., D.G., S.D.L., M.P.F., M.E.C.), and the C.S. Kubik Laboratory for Neuropathology (D.H.O., M.P.F.), Massachusetts General Hospital and Harvard Medical School, Boston.
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2020-07-09
- Volume
- 383
- Issue
- 2
- Pages
- 151-158
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- PMC
- PMC11836664
- OpenAlex
- W3041917243
- Cited by
- 264
- References
- 17
- Citations by year
- 2026: 32 · 2025: 34 · 2024: 54 · 2023: 41 · 2022: 59 · 2021: 31 · 2020: 13
- FWCI
- 15.59
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Cellucci Fund for ALS Research
- Max Rosenfeld ALS Research Fund
- National Institute of Neurological Disorders and Stroke
- Amyotrophic Lateral Sclerosis Association
- ALS-Finding a Cure
- Angel Fund for ALS Research
- Topics
- Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
- Health Sciences › Medicine › Genetics (clinical) › Neurogenetic and Muscular Disorders Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Keywords
- familial ALS, SOD1, adeno-associated virus, microRNA, intrathecal gene therapy, spinal cord, meningoradiculitis, immunosuppression, vital capacity
- MeSH terms
- Superoxide Dismutase-1, Proof of Concept Study, Dependovirus, Amyotrophic Lateral Sclerosis, Genetic Vectors, Humans, Injections, Spinal, Male, Meningoencephalitis, Middle Aged, Mutation, Spinal Cord, Vital Capacity, Genetic Therapy, Fatal Outcome, Gene Silencing, MicroRNAs, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: SOD1 Suppression with Adeno-Associated Virus and MicroRNA in Familial ALS. https://app.cochat.ai/papers/10.1056/nejmoa2005056
- The paper
- Mueller, C., Berry, J. D., McKenna-Yasek, D. M., Gernoux, G., Owegi, M. A., Pothier, L. M., Douthwright, C. L., Gelevski, D., Luppino, S. D., Blackwood, M., Wightman, N. S., Oakley, D. H., Frosch, M. P., Flotte, T. R., Cudkowicz, M. E., & Brown, R. H. (2020). SOD1 Suppression with Adeno-Associated Virus and MicroRNA in Familial ALS. New England Journal of Medicine. https://doi.org/10.1056/nejmoa2005056
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.